2025 ASPN Guidelines for SCS / Neurostimulation for the Treatment of Non-Surgical Low Back Pain - Guideline Summary - Guideline Central
Summary of Recommendations
Document Overview

Neurostimulation for the Treatment of Non-Surgical Low Back Pain

American Society of Pain and Neuroscience


Publication Date: Mar 14, 2025

Page Last Updated: May 5, 2026


Recommendation Grading

 

Document Overview

Document Title
Use of Neurostimulation for the Treatment of Non-Surgical Low Back Pain
Authoring Society

American Society of Pain and Neuroscience

Document Publication Date
Mar 14, 2025
Page Last Reviewed/Updated
May 5, 2026
Document Type
Consensus Statement
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
www.dovepress.com/an-evidence-based-consensus-for-the-use-of-neurostimulation-for-the-tr-peer-reviewed-fulltext-article-JPR
Source Citation

Deer TR, Pope JE, Petersen EA, Abdallah RT, Amirdelfan K, Azeem N, Bansal V, Barkoh K, Chapman KB, Denis DR, Dorsi MJ, Escobar A, Falowski SM, Garcia RA, Hagedorn JM, Heros RD, James WS, Kalia H, Lansford T, Malinowski MN, Manzi SM, Mehta P, Moghim RZ, Moore GA, Motivala SL, Navalgund YA, Patel RG, Pilitsis JG, Schatman ME, Shumsky PM, Strand NH, Tomycz ND, Yue JJ, Sayed D. An Evidence-Based Consensus for the Use of Neurostimulation for the Treatment of Non-Surgical Low Back Pain: The NEURON Group. J Pain Res. 2025;18:1247-1274


Document Scope, Criteria, and Use Cases

Document Objectives
The use of electrical neuromodulation has often been limited to those with previous back surgery, peripheral neuropathy, and complex regional pain syndrome. Many patients with severe intractable low back pain were thought to be candidates for spinal cord stimulation (SCS), dorsal root ganglion stimulation, or peripheral nerve stimulation but did not meet the criteria. Recently, additional high-level data has supported the use of SCS in non-surgical low back pain (NSLBP), and United States Food and Drug Administration approval has been granted. The American Society of Pain and Neuroscience (ASPN) executive committee realized an unmet need to develop criteria for patient selection for this specific patient population. This is a NEURON project (neuroscience, education, utilization, risk mitigation, optimal outcomes, and neuromodulation), a living guideline for evolving therapies and indications, and is focused on the use of neuraxial stimulation for the treatment of refractory pain. The selection of patients for implantation in those who have NSLBP should be based on published literature, best practice, and expert opinion. This NEURON project will allow for regular updates to create a living guideline that will allow for better assimilation of information to improve safety and efficacy going forward.
Scope
Management
Diseases/Conditions (MeSH)

D062187 - Spinal Cord Stimulation

D017116 - Low Back Pain

D062187 - Spinal Cord Stimulation

D017116 - Low Back Pain

Keywords
low back pain, lumbar degenerative disc disease, spinal cord stimulation
Inclusion Criteria
Male, Female, Adult, Older Adult
Health Care Settings
Ambulatory, Operating and Recovery Room, Outpatient
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.